Laves-Arzneimittel GmbH

Name: Laves-Arzneimittel GmbH
Telephone: +41 41 984 05 00

Swiss Biotech Association

Member

Laves-Arzneimittel GmbH has focused on the exploration and development of preparations based on the probiotic Escherichia coli strain Laves discovered in 1931 by Dr. Wolfgang Laves.

http://www.laves-pharma.de
+41 41 984 05 00
info@laves-pharma.ch
Viktor Helbing

Location

Lavesstrasse, 6247 Schötz, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

1908
Number of employees in Switzerland

10-19

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Solvias AG

Solvias is a contract research, development & manufacturing
We offer early phase development of small molecules API by process R&D and GMP-manufacturing integrated with high through-put screening, solid state and a wide ligand portfolios for catalytic transformations and analytical services.
Kaiseraugst

Member

Porton Pharmaceutical Chemicals GmbH

Porton Pharma is a a leading CDMO with operations and commercial offices across the US, EU and China. Porton Pharma provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecules, dosage forms and biologics.
6039 Root

Member

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member